Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by investclubon Nov 15, 2019 11:07am

120 Views

Post# 30356530

RE:RE:RE:RE:RE:RE:RE:RE:RE:Ph2 results

Mineking66 wrote
Only one institutional investor with a measly 103000 shares tells me they are staying away yet..
Not good..

Hi Mineking66 I expect we will see more Institutional investment take place after reasonable to strong proof shows that this treatment does work with high results remember outside of oncologist and shareholders most are sceptical. Bottom line is they want proof then they will buy and buy and buy.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario